United States Biotechnology & Medical Research

Kezar Life Sciences Inc (KZR)

Track

Track

Ticker: KZR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kezar Life Sciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Schiller Mark C. Chief Operating Officer Officer
Transaction date
Sale
Price
205.23
Quantity 29,529 +33.0%
Value US$998,422
2.1
Chiang Pichi Luo SVP, Corporate Controller Officer
Transaction date
Sale
Price
16.51
Quantity 10,457 -14.3%
Value US$1,996,358
1.6
Schiller Mark C. Chief Legal Officer Officer
Transaction date
Sale
Price
145.65
Quantity 10,392 -7.6%
Value US$3,578,228
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Purchase
Price
14.77
Quantity 20,000 +2.3%
Value US$295,400
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 45,000 +5.4%
Value US$765,000
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Purchase
Price
15.96
Quantity 15,000 +1.9%
Value US$239,400
3.9
Kauffman Michael Non-Executive Director
Transaction date
Planned sale
Price
16.45
Quantity 5,000 -7.3%
Value US$82,250
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Purchase
Price
5.50
Quantity 100,000 +14.6%
Value US$550,000
Kirk Christopher J. President and CSO Executive Director
Transaction date
Planned purchase
Price
2.60
Quantity 38,461 +12.6%
Value US$99,999
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Purchase
Price
2.60
Quantity 120,846 +21.5%
Value US$314,200
1.7
Economides Vassiliki SVP, Strategy & External Aff. Officer
Transaction date
Purchase
Price
2.60
Quantity 5,769 +320.3%
Value US$14,999
0.8
Belsky Marc CFO Officer
Transaction date
Purchase
Price
2.60
Quantity 15,384 +inf%
Value US$39,998
2.3
Fowler John Franklin CEO Executive Director
Transaction date
Purchase
Price
2.60
Quantity 38,461 +inf%
Value US$99,999
Belsky Marc CFO Officer
Transaction date
Purchase
Price
2.76
Quantity 800 +66.7%
Value US$2,207
2.3
Fowler John Franklin CEO Executive Director
Transaction date
Purchase
Price
3.24
Quantity 1,000 +0.3%
Value US$3,235
Belsky Marc CFO Officer
Transaction date
Purchase
Price
4.42
Quantity 200 +20.0%
Value US$884
Economides Vassiliki SVP, Strategy & External Aff. Officer
Transaction date
Purchase
Price
4.41
Quantity 350 +24.1%
Value US$1,544
Kirk Christopher J. President and CSO Executive Director
Transaction date
Purchase
Price
4.61
Quantity 5,000 +1.7%
Value US$23,040
Fowler John Franklin CEO Executive Director
Transaction date
Purchase
Price
4.66
Quantity 2,000 +0.7%
Value US$9,310
Economides Vassiliki SVP, Strategy & External Aff. Officer
Transaction date
Purchase
Price
4.96
Quantity 1,020 +236.7%
Value US$5,057
Belsky Marc CFO Officer
Transaction date
Purchase
Price
4.82
Quantity 500 +100.0%
Value US$2,410
Kirk Christopher J. President and CSO Executive Director
Transaction date
Planned purchase
Price
4.97
Quantity 5,000 +1.7%
Value US$24,830
Fowler John Franklin CEO Executive Director
Transaction date
Purchase
Price
5.01
Quantity 750 +0.3%
Value US$3,761
Fowler John Franklin CEO Executive Director
Transaction date
Purchase
Price
5.26
Quantity 500 +0.2%
Value US$2,628
0.8
Belsky Marc CFO
Transaction date
Purchase
Price
5.80
Quantity 56 +12.6%
Value US$325
0.8
Belsky Marc CFO
Transaction date
Purchase
Price
5.65
Quantity 444 +inf%
Value US$2,510
1.7
Economides Vassiliki SVP, Strategy & External Aff.
Transaction date
Purchase
Price
5.82
Quantity 431 +inf%
Value US$2,509
1.7
Economides Vassiliki SVP, Strategy & External Aff. Officer
Transaction date
Planned purchase
Price
10.19
Quantity 750 +7.1%
Value US$7,642
BAY CITY CAPITAL LLC Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 150,000 +31.8%
Value US$2,250,000
Cormorant Asset Management, LP Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 250,000 +18.9%
Value US$3,750,000
Morningside Venture Investments Ltd Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 250,000 +12.1%
Value US$3,750,000
BERGER FRANKLIN M
Transaction date
Purchase
Price
15.00
Quantity 50,000 +9.7%
Value US$750,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-03 2025-07-02 S Sale
1.6
Schiller Mark C.

Chief Operating Officer

Officer
29,529 +33.0%
205.23
US$998,422 		29,529 +33.0% 205.23 US$998,422
2025-07-03 2025-07-02 S Sale
2.1
Chiang Pichi Luo

SVP, Corporate Controller

Officer
10,457 -14.3%
16.51
US$1,996,358 		10,457 -14.3% 16.51 US$1,996,358
2024-07-26 2024-07-02 S Sale
1.6
Schiller Mark C.

Chief Legal Officer

Officer
10,392 -7.6%
145.65
US$3,578,228 		10,392 -7.6% 145.65 US$3,578,228
2023-02-07 2023-02-06 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
40,000 -0.7%
6.88
US$275,320 		40,000 -0.7% 6.88 US$275,320
2023-02-07 2023-02-03 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
25,000 -0.5%
7.15
US$178,650 		25,000 -0.5% 7.15 US$178,650
2023-02-03 2023-02-02 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
50,000 -0.9%
7.19
US$359,500 		50,000 -0.9% 7.19 US$359,500
2023-02-03 2023-02-01 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
40,000 -0.7%
6.95
US$278,000 		40,000 -0.7% 6.95 US$278,000
2023-02-01 2023-01-31 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
30,000 -0.5%
7.08
US$212,400 		30,000 -0.5% 7.08 US$212,400
2023-02-01 2023-01-30 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
30,000 -0.5%
6.91
US$207,300 		30,000 -0.5% 6.91 US$207,300
2023-01-27 2023-01-25 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
50,000 -0.9%
6.85
US$342,500 		50,000 -0.9% 6.85 US$342,500
2023-01-25 2023-01-24 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
80,000 -1.4%
6.98
US$558,400 		80,000 -1.4% 6.98 US$558,400
2023-01-25 2023-01-23 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
80,000 -1.4%
6.81
US$544,800 		80,000 -1.4% 6.81 US$544,800
2023-01-19 2023-01-17 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
6,114 -0.1%
6.79
US$41,514 		6,114 -0.1% 6.79 US$41,514
2023-01-17 2023-01-13 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
1,971 -0.0%
7.15
US$14,093 		1,971 -0.0% 7.15 US$14,093
2023-01-17 2023-01-12 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
5,000 -0.1%
6.77
US$33,850 		5,000 -0.1% 6.77 US$33,850
2023-01-09 2023-01-06 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
3,000 -0.1%
6.89
US$20,670 		3,000 -0.1% 6.89 US$20,670
2023-01-09 2023-01-05 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
12,162 -0.2%
6.97
US$84,769 		12,162 -0.2% 6.97 US$84,769
2023-01-05 2023-01-04 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
30,000 -0.5%
7.17
US$215,100 		30,000 -0.5% 7.17 US$215,100
2023-01-05 2023-01-03 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
500 -0.0%
7.10
US$3,550 		500 -0.0% 7.10 US$3,550
2023-01-05 2022-12-29 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
25,000 -0.4%
7.10
US$177,500 		25,000 -0.4% 7.10 US$177,500
2022-10-05 2022-10-04 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
3,612 -0.1%
8.82
US$31,857 		3,612 -0.1% 8.82 US$31,857
2022-10-05 2022-10-03 S Sale
3.5
Morningside Venture Investments Ltd
Large shareholder
28,700 -0.5%
8.78
US$251,957 		28,700 -0.5% 8.78 US$251,957
2022-03-22 2022-03-21 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
20,000 +2.3%
14.77
US$295,400 		20,000 +2.3% 14.77 US$295,400
2022-03-22 2022-03-18 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
45,000 +5.4%
17.00
US$765,000 		45,000 +5.4% 17.00 US$765,000
2022-03-22 2022-03-18 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
15,000 +1.9%
15.96
US$239,400 		15,000 +1.9% 15.96 US$239,400
2022-01-05 2022-01-03 PlS Planned sale
3.9
Kauffman Michael
Non-Executive Director
5,000 -7.3%
16.45
US$82,250 		5,000 -7.3% 16.45 US$82,250
2020-06-15 2020-06-11 B Purchase
0.8
Equal Talent Investments Ltd
Large shareholder
1,454,545 +30.3%
5.50
US$7,999,998 		1,454,545 +30.3% 5.50 US$7,999,998
2020-06-11 2020-06-11 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
100,000 +14.6%
5.50
US$550,000 		100,000 +14.6% 5.50 US$550,000
2020-02-06 2020-02-04 B Purchase
3.5
Morningside Venture Investments Ltd
Large shareholder
3,800,000 +164.6%
2.60
US$9,880,000 		3,800,000 +164.6% 2.60 US$9,880,000
2020-02-05 2020-02-04 PP Planned purchase
Kirk Christopher J.

President and CSO

Executive Director
38,461 +12.6%
2.60
US$99,999 		38,461 +12.6% 2.60 US$99,999
2020-02-05 2020-02-04 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
120,846 +21.5%
2.60
US$314,200 		120,846 +21.5% 2.60 US$314,200
2020-02-05 2020-02-04 B Purchase
1.7
Economides Vassiliki

SVP, Strategy & External Aff.

Officer
5,769 +320.3%
2.60
US$14,999 		5,769 +320.3% 2.60 US$14,999
2020-02-05 2020-02-04 B Purchase
0.8
Belsky Marc

CFO

Officer
15,384 +inf%
2.60
US$39,998 		15,384 +inf% 2.60 US$39,998
2020-02-05 2020-02-04 B Purchase
2.3
Fowler John Franklin

CEO

Executive Director
38,461 +inf%
2.60
US$99,999 		38,461 +inf% 2.60 US$99,999
2019-11-13 2019-11-13 B Purchase Belsky Marc

CFO

Officer
800 +66.7%
2.76
US$2,207 		800 +66.7% 2.76 US$2,207
2019-10-11 2019-10-10 B Purchase
2.3
Fowler John Franklin

CEO

Executive Director
1,000 +0.3%
3.24
US$3,235 		1,000 +0.3% 3.24 US$3,235
2019-08-21 2019-08-20 B Purchase Belsky Marc

CFO

Officer
200 +20.0%
4.42
US$884 		200 +20.0% 4.42 US$884
2019-08-21 2019-08-20 B Purchase Economides Vassiliki

SVP, Strategy & External Aff.

Officer
350 +24.1%
4.41
US$1,544 		350 +24.1% 4.41 US$1,544
2019-08-15 2019-08-13 B Purchase Kirk Christopher J.

President and CSO

Executive Director
5,000 +1.7%
4.61
US$23,040 		5,000 +1.7% 4.61 US$23,040
2019-08-14 2019-08-13 B Purchase Fowler John Franklin

CEO

Executive Director
2,000 +0.7%
4.66
US$9,310 		2,000 +0.7% 4.66 US$9,310
2019-08-12 2019-08-09 B Purchase Economides Vassiliki

SVP, Strategy & External Aff.

Officer
1,020 +236.7%
4.96
US$5,057 		1,020 +236.7% 4.96 US$5,057
2019-08-12 2019-08-09 B Purchase Belsky Marc

CFO

Officer
500 +100.0%
4.82
US$2,410 		500 +100.0% 4.82 US$2,410
2019-08-12 2019-08-09 PP Planned purchase Kirk Christopher J.

President and CSO

Executive Director
5,000 +1.7%
4.97
US$24,830 		5,000 +1.7% 4.97 US$24,830
2019-08-12 2019-08-09 B Purchase Fowler John Franklin

CEO

Executive Director
750 +0.3%
5.01
US$3,761 		750 +0.3% 5.01 US$3,761
2019-08-12 2019-08-09 B Purchase Fowler John Franklin

CEO

Executive Director
500 +0.2%
5.26
US$2,628 		500 +0.2% 5.26 US$2,628
2019-07-26 2019-07-26 B Purchase
0.8
Belsky Marc

CFO
56 +12.6%
5.80
US$325 		56 +12.6% 5.80 US$325
2019-07-26 2019-07-25 B Purchase
0.8
Belsky Marc

CFO
444 +inf%
5.65
US$2,510 		444 +inf% 5.65 US$2,510
2019-07-23 2019-07-22 B Purchase
1.7
Economides Vassiliki

SVP, Strategy & External Aff.
431 +inf%
5.82
US$2,509 		431 +inf% 5.82 US$2,509
2021-03-29 2019-05-30 PP Planned purchase
1.7
Economides Vassiliki

SVP, Strategy & External Aff.

Officer
750 +7.1%
10.19
US$7,642 		750 +7.1% 10.19 US$7,642
2018-06-28 2018-06-25 B Purchase BAY CITY CAPITAL LLC Large shareholder
150,000 +31.8%
15.00
US$2,250,000 		150,000 +31.8% 15.00 US$2,250,000
2018-06-27 2018-06-25 B Purchase Cormorant Asset Management, LP Large shareholder
250,000 +18.9%
15.00
US$3,750,000 		250,000 +18.9% 15.00 US$3,750,000
2018-06-27 2018-06-25 B Purchase Morningside Venture Investments Ltd Large shareholder
250,000 +12.1%
15.00
US$3,750,000 		250,000 +12.1% 15.00 US$3,750,000
2018-06-27 2018-06-25 B Purchase BERGER FRANKLIN M
50,000 +9.7%
15.00
US$750,000 		50,000 +9.7% 15.00 US$750,000
Explore more

More insider trading research around Kezar Life Sciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America